73 related articles for article (PubMed ID: 23278283)
1. Risk prediction in stable angina pectoris.
Kahan T; Forslund L; Held C; Björkander I; Billing E; Eriksson SV; Näsman P; Rehnqvist N; Hjemdahl P
Eur J Clin Invest; 2013 Feb; 43(2):141-51. PubMed ID: 23278283
[TBL] [Abstract][Full Text] [Related]
2. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of renal dysfunction in patients with stable angina pectoris.
Almquist T; Forslund L; Rehnqvist N; Hjemdahl P
J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004
[TBL] [Abstract][Full Text] [Related]
4. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris.
Held C; Björkander I; Forslund L; Rehnqvist N; Hjemdahl P
Diabet Med; 2005 Oct; 22(10):1326-33. PubMed ID: 16176191
[TBL] [Abstract][Full Text] [Related]
5. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.
Forslund L; Björkander I; Ericson M; Held C; Kahan T; Rehnqvist N; Hjemdahl P
Heart; 2002 May; 87(5):415-22. PubMed ID: 11997407
[TBL] [Abstract][Full Text] [Related]
8. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
[TBL] [Abstract][Full Text] [Related]
14. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris.
Svingen GF; Ueland PM; Pedersen EK; Schartum-Hansen H; Seifert R; Ebbing M; Løland KH; Tell GS; Nygård O
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):2041-8. PubMed ID: 23723367
[TBL] [Abstract][Full Text] [Related]
15. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
[TBL] [Abstract][Full Text] [Related]
17. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
IONA Study Group
Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction.
Wallén NH; Held C; Rehnqvist N; Hjemdahl P
Eur Heart J; 1999 Jul; 20(14):1039-43. PubMed ID: 10381855
[TBL] [Abstract][Full Text] [Related]
19. Negative and positive predictive values of routine exercise testing in stable, medically-treated patients several years following a Q-wave myocardial infarction.
Casella G; Pavesi PC; Niro MD; Bracchetti D
Ital Heart J; 2001 Apr; 2(4):271-9. PubMed ID: 11374496
[TBL] [Abstract][Full Text] [Related]
20. [Dobutamine stress echocardiography in patients with stable chronic angina and a low- or medium-risk on exercise testing: usefulness for assessing long-term prognosis].
Castillo-Moreno JA; Ramos-Martín JL; Molina-Laborda E; Florenciano-Sánchez R; Ortega-Bernal J
Rev Esp Cardiol; 2005 Aug; 58(8):916-23. PubMed ID: 16053825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
